IDH1 Gene IDH1 Selective Sequencing of Exon 4 Genetic Test
At DNA Labs UAE, we offer the IDH1 Gene IDH1 selective sequencing of exon 4 Genetic Test. This test is designed to analyze the IDH1 gene, also known as isocitrate dehydrogenase 1, which plays a crucial role in cellular metabolism.
Test Components
- Price: 4400.0 AED
Sample Condition
The test can be performed using blood, extracted DNA, or one drop of blood on an FTA card.
Report Delivery
The test results will be delivered within 3 to 4 weeks.
Method
The IDH1 Gene IDH1 selective sequencing of exon 4 Genetic Test utilizes Next-Generation Sequencing (NGS) technology. This advanced sequencing method allows for the simultaneous sequencing of multiple DNA fragments, making it faster and more cost-effective than traditional sequencing methods.
Test Type
The IDH1 Gene IDH1 selective sequencing of exon 4 Genetic Test is specifically designed for the detection of cancer-related mutations.
Doctor
This test is recommended for oncologists who specialize in the diagnosis and treatment of cancer.
Test Department
The IDH1 Gene IDH1 selective sequencing of exon 4 Genetic Test is conducted in our Genetics department.
Pre Test Information
Prior to undergoing the IDH1 Gene IDH1 selective sequencing of exon 4 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by the IDH1 gene mutations.
Test Details
The IDH1 gene, also known as isocitrate dehydrogenase 1, is a gene that encodes an enzyme involved in cellular metabolism. Mutations in the IDH1 gene have been associated with various cancers, including gliomas, acute myeloid leukemia, and chondrosarcoma.
Selective sequencing of exon 4 refers to a specific method of genetic testing that focuses on sequencing only the fourth exon of the IDH1 gene. Exons are the coding regions of genes that contain the instructions for protein synthesis. By selectively sequencing exon 4, researchers can identify specific mutations or variations within this region of the IDH1 gene.
Next-generation sequencing (NGS) technology is utilized in this test. It is a high-throughput method used for sequencing DNA, allowing for the analysis of large amounts of genetic data in a short period of time. This technology has revolutionized genetic testing and research, enabling faster and more cost-effective analysis.
The selective sequencing of exon 4 using NGS technology allows for the identification of mutations or variations within the IDH1 gene. This information can be used for diagnostic purposes, prognostic assessments, or to guide personalized treatment options.
Test Name | IDH1 Gene IDH1 selective sequencing of exon 4 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cancer |
Doctor | Oncologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for IDH1 Gene IDH1, selective sequencing of exon 4 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IDH1 Gene IDH1, selective sequencing of exon 4 NGS Genetic DNA Test gene IDH1 |
Test Details |
The IDH1 gene, also known as isocitrate dehydrogenase 1, is a gene that encodes an enzyme involved in cellular metabolism. Mutations in the IDH1 gene have been found to be associated with various cancers, including gliomas, acute myeloid leukemia, and chondrosarcoma. Selective sequencing of exon 4 refers to a specific method of genetic testing that focuses on sequencing only the fourth exon of the IDH1 gene. Exons are the coding regions of genes that contain the instructions for protein synthesis. By selectively sequencing exon 4, researchers can identify specific mutations or variations within this region of the IDH1 gene. Next-generation sequencing (NGS) is a high-throughput method used for sequencing DNA. It allows for the simultaneous sequencing of multiple DNA fragments, making it faster and more cost-effective than traditional sequencing methods. NGS technology has revolutionized genetic testing and research, enabling the analysis of large amounts of genetic data in a short period. Therefore, selective sequencing of exon 4 using NGS technology allows for the identification of mutations or variations within the IDH1 gene that may be associated with certain diseases or conditions. This information can be used for diagnostic purposes, prognostic assessments, or to guide personalized treatment options. |